| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/12/2011 | EP2273268A2 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 01/12/2011 | EP2272869A2 Angiopoietin-2 specific binding agents |
| 01/12/2011 | EP2272844A1 Five-membered ring compound |
| 01/12/2011 | EP2272835A1 Novel five-membered ring compound |
| 01/12/2011 | EP2272518A1 Hypotensive lipid (prostaglandin derivatives) and timolol compositions and methods of using same |
| 01/12/2011 | EP2272513A1 Pharmaceutical compositions for treating cancer |
| 01/12/2011 | EP2272512A1 Pharmaceutical compositions for treating cancer |
| 01/12/2011 | EP2271405A2 Nip thiazole derivatives as inhibitors of 11-beta-hydorxysteroid dehydrogenase-1 |
| 01/12/2011 | EP2271337A1 Beta-turn peptidomimetic cyclic compounds for treating dry eye |
| 01/12/2011 | EP1587468B1 Eyelid margin wipes comprising chemical means for temperature adjustment |
| 01/12/2011 | EP1402266B1 Reducing RISK OF COMPLICATIONS OF PREMATURITY |
| 01/12/2011 | CN1816566B VEGF traps and therapeutic uses thereof |
| 01/12/2011 | CN101945656A Novel use of 3,3'-diindolylmethane |
| 01/12/2011 | CN101945653A Compositions and methods for treating neurodegenerative diseases |
| 01/12/2011 | CN101942012A Polypeptide for preventing and treating angiogenesis and application thereof |
| 01/12/2011 | CN101940769A Myopia and hyperopia treating pill |
| 01/12/2011 | CN101940735A Chinese medicinal herb for treating Meniere's disease |
| 01/12/2011 | CN101940701A Aloe oculentum and preparation method |
| 01/12/2011 | CN101940660A Chinese medicament for treating diabetic retinopathy |
| 01/12/2011 | CN101940659A Traditional Chinese medicine for treating diabetic eye disease |
| 01/12/2011 | CN101940623A Antibiotic and antiphlogistic medicinal composition and preparation method thereof |
| 01/12/2011 | CN101940571A Anti-angiogenic agents and methods of use |
| 01/12/2011 | CN101940553A Folic acid-vincristine targeted and slow-released nano-microspheres, prepared method and application thereof |
| 01/12/2011 | CN101940419A Novel health-care pillow |
| 01/12/2011 | CN101137359B Methods of treating ear infections |
| 01/11/2011 | CA2462390C Anthranilic acid amides and pharmaceutical use thereof |
| 01/11/2011 | CA2451678C Azaindoles |
| 01/11/2011 | CA2430124C Lactam compounds and pharmaceutical use thereof |
| 01/11/2011 | CA2420592C Fused pyrrolocarbazoles against inflammation |
| 01/11/2011 | CA2400486C Aniline-derived ligands for the thyroid receptor |
| 01/11/2011 | CA2309541C Vegi, an inhibitor of angiogenesis and tumor growth |
| 01/06/2011 | WO2011003103A2 Pharmacology of visual cycle modulators |
| 01/06/2011 | WO2011003091A1 Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections |
| 01/06/2011 | WO2011001951A1 Ophthalmic composition |
| 01/06/2011 | WO2011001634A1 Method for improving bioavailability of latanoprost |
| 01/06/2011 | WO2010102196A3 Controlled-release ophthalmic vehicles |
| 01/06/2011 | WO2010102192A3 Non-steroidal anti-inflammatory ophthalmic compositions |
| 01/06/2011 | WO2010056985A8 Treatment of proteinopathies using a farnesyl transferase inhibitor |
| 01/06/2011 | US20110004304 Culturing retinal cells and tissues |
| 01/06/2011 | US20110003987 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors |
| 01/06/2011 | US20110003891 Novel use of zinc n-acetyltaurinate |
| 01/06/2011 | US20110003880 Compositions and methods for inhibiting optic nerve damage |
| 01/06/2011 | US20110003876 Tetrahydroindoles Having Sphingosine-1-Phosphate Receptor Activity |
| 01/06/2011 | US20110003853 Metalloproteinase Inhibitors |
| 01/06/2011 | US20110003843 Novel compounds derived from indole and pharmaceutical compositions containing them |
| 01/06/2011 | US20110003824 Caspase Inhibitors and Uses Thereof |
| 01/06/2011 | US20110003816 Ophthalmic composition |
| 01/06/2011 | US20110003810 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors |
| 01/06/2011 | US20110003803 Compositions and methods for treating ophthalmic, otic, or nasal infections |
| 01/06/2011 | US20110003784 Opsin-binding ligands, compositions and methods of use |
| 01/06/2011 | US20110003766 Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as a2ar agonists |
| 01/06/2011 | US20110003761 Biologically active extract from dendrobium plant, use thereof and process for preparing the same |
| 01/06/2011 | US20110003756 C5a Receptor Antagonists |
| 01/06/2011 | US20110003750 Human 3 relaxin |
| 01/06/2011 | US20110003388 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
| 01/06/2011 | US20110003003 Magnetic cells for localizing delivery and tissue repair |
| 01/06/2011 | US20110002912 Composition |
| 01/06/2011 | US20110002910 Therapeutic agents comprising pro-apoptotic proteins |
| 01/06/2011 | CA2766269A1 Method for improving bioavailability of latanoprost |
| 01/06/2011 | CA2766178A1 Combretastatins for prevention of posterior capsule opacification |
| 01/06/2011 | CA2765852A1 Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections |
| 01/05/2011 | EP2270177A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/05/2011 | EP2270176A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/05/2011 | EP2270175A1 Streptococcus pneumoniae proteins and nucleic acids |
| 01/05/2011 | EP2270171A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 01/05/2011 | EP2270049A2 Recombinant anti-interleukin-9-antibody |
| 01/05/2011 | EP2270042A2 KDR peptides and vaccines comprising the same |
| 01/05/2011 | EP2270041A2 KDR peptides and vaccines comprising the same |
| 01/05/2011 | EP2270005A1 Prodrug of an ice inhibitor |
| 01/05/2011 | EP2269988A2 Anthranilic acid amides and pharmaceutical use thereof |
| 01/05/2011 | EP2269656A2 Selected antibodies binding to anionic phospholipids and aminophospholipids and their use in treatment |
| 01/05/2011 | EP2269612A1 Eye-drop preparation and use thereof |
| 01/05/2011 | EP2269609A2 Treatment of neurodegenerative diseases and cancer of the brain with SAHA |
| 01/05/2011 | EP2269602A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 01/05/2011 | EP2269576A2 A Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 01/05/2011 | EP2268275A2 Antimicrobials having polyquarternary ammoniums and alcohol-bearing amidoamines and methods for their use |
| 01/05/2011 | EP2178504B1 Preservative-free prostaglandin-based ophthalmic solution |
| 01/05/2011 | EP1937281B1 Modulation of trpv expression levels |
| 01/05/2011 | EP1812387B1 2,3,4-substituted cyclopentanones as therapeutic agents |
| 01/05/2011 | EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 01/05/2011 | EP1446381B1 Anthranilic acid amides and pharmaceutical use thereof |
| 01/05/2011 | CN101939291A Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor |
| 01/05/2011 | CN101939000A Materials and methods for treatment of pathological ocular vascular proliferation |
| 01/05/2011 | CN101935363A Method for producing pharmaceutical grade hyaluronic acid |
| 01/05/2011 | CN101935349A Humanized monoclonal antibody against human vascular endothelial growth factor and preparation and application thereof |
| 01/05/2011 | CN101935318A 2,3-dihydro-4(1H)- quinazolone derivative and application thereof |
| 01/05/2011 | CN101935301A Modulators of ATP-binding cassette transporters |
| 01/05/2011 | CN101933996A Chinese medicinal composition having effects of clearing heat, relieving fire and eliminating toxins and preparation and detection methods thereof |
| 01/05/2011 | CN101933905A Liposome composition for conveying eye treatment medicament |
| 01/04/2011 | US7863475 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/04/2011 | US7863312 Pyrazolidinone derivatives, e.g., 4-[2-(2-(3-hydroxyoctyl)-5-oxopyrazolidin-1-yl)ethyl]benzoic acid; treating preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, (pre)eclampsia, or eosinophil disorders |
| 01/04/2011 | CA2491871C Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 01/04/2011 | CA2491027C Novel flavone c-glycoside derivatives and compositions containing the derivatives |
| 01/04/2011 | CA2474703C Therapeutic agent of glaucoma comprising bunazosin and prostaglandins |
| 01/04/2011 | CA2460822C Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing same |
| 01/04/2011 | CA2449054C Integrin targeting liposome for nucleic acid delivery |
| 01/04/2011 | CA2443728C Pharmaceutical composition based on macrolides for topical application in ophthalmology |
| 01/04/2011 | CA2401545C Mutated cyclin g1 protein |
| 12/30/2010 | US20100331430 Pharmaceutical compositions containing propionic preservative components |
| 12/30/2010 | US20100331410 Biaryl Amides |